Ethyl Acetate → 3(S)-[(Carbobenzyloxy)amino]-2,3-dihydro-1,5-benzothiazepin-4(5H)-one
反応式
[NH2:1][C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][C:3]=1[S:8][CH2:9][C@H:10]([C:22]([OH:24])=O)[NH:11][C:12]([O:14][CH2:15][C:16]1[CH:21]=[CH:20][CH:19]=[CH:18][CH:17]=1)=[O:13].Cl.CN(C)CCCN=C=NCC.C(OCC)(=O)C>CN(C=O)C>[C:12]([NH:11][C@H:10]1[C:22](=[O:24])[NH:1][C:2]2[CH:7]=[CH:6][CH:5]=[CH:4][C:3]=2[S:8][CH2:9]1)([O:14][CH2:15][C:16]1[CH:21]=[CH:20][CH:19]=[CH:18][CH:17]=1)=[O:13]参加物
5
反応物 3
生成物 1
試薬・触媒・溶媒 1
実験手順
A mixture of 13.10 g (37.9 mmol) of S-(o-aminophenyl)-N-carbobenzyloxy-D-cysteine and 7.27 g (37.9 mmol) of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride in 82 mL of DMF was stirred at room temperature for 2 hours. To this solution was added 330 mL of ethyl acetate. The mixture was extracted 4 times with 200 mL of 1N NaOH. The ethyl acetate solution was dried with magnesium sulfate (MgSO4) and evaporated to a white amorphous residue. The residue was triturated with ether, and the resulting white crystals were filtered to yield 6.70 g (54%) of 3(S)-[(Carbobenzyloxy)amino]-2,3-dihydro-1,5-benzothiazepin-4(5H)-one as a white solid.
後処理
- extractionThe mixture was extracted 4 times with 200 mL of 1N NaOH
- dry with materialThe ethyl acetate solution was dried with magnesium sulfate (MgSO4)
- customevaporated to a white amorphous residue
- customThe residue was triturated with ether
- filtrationthe resulting white crystals were filtered
出典と根拠
- ORDレコード
- ord-bee5f94e094841a3a51baed91aa2ce2c
- 出典データセット
- uspto-grants-1997_04
- 特許番号
- US05618808
反応ノート
読み込み中…